AK112 Injection

Drug identity checked against registry records

Also recorded as Carboplatin; Pemetrexed

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Phase III Study of AK112 for NSCLC PatientsNCT06396065Summit TherapeuticsPhase 3Active not recruiting2025-04-12Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.